This medicine is a prescription medication that combines two active ingredients: dapagliflozin (5 mg) and metformin hydrochloride (500 mg). It is primarily used to manage blood sugar levels in adults with type 2 diabetes.

Benefits:
-Helps lower blood sugar levels effectively in patients with type 2 diabetes.
-May aid in weight loss or weight maintenance due to the caloric loss associated with glucose excretion.
-Can improve cardiovascular health by reducing the risk of heart-related issues in diabetic patients.
-The extended-release formulation allows for once-daily dosing, enhancing patient compliance.

Precautions:
-Not recommended for individuals with severe renal impairment or end-stage renal disease.
-Caution should be exercised in patients with a history of urinary tract infections or genital mycotic infections, as SGLT2 inhibitors can increase the risk of these conditions.
-Monitor kidney function regularly during treatment.
-Patients should be aware of the signs of lactic acidosis, which can occur with metformin use, especially in those with renal issues or dehydration.

Side Effects:
-Common side effects may include nausea, diarrhea, headache, and dizziness.
-Serious side effects can include lactic acidosis, acute kidney injury, urinary tract infections, and dehydration.
-Patients may also experience genital fungal infections due to increased glucose in urine.

Main Ingredients and Their Benefits:
- Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood glucose levels by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine.
- Metformin hydrochloride is a biguanide that improves insulin sensitivity and decreases hepatic glucose production, thereby helping to control blood sugar levels in individuals with type 2 diabetes.